Recruiting studies: Cox 2 Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Colorectal Metastasis Prevention International Trial 2
Phase 2 · 6 location(s) · Assaf-Harofeh Medical Center · NCT03919461 Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT05434065 Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06903858 Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Phase 2 · 2 location(s) · Tel-Aviv Sourasky Medical Center · NCT06839144 Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
NA · 1 location(s) · New Valley University · NCT06697106 Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Phase 2 · 5 location(s) · Fudan University · NCT07154316 Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MS
Phase 2 · 1 location(s) · Fudan University · NCT07150949

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.